Today: 21 June 2026

Booking Holdings (BKNG) Stock News, Forecasts, and Analysis for Dec. 20, 2025: Court Ruling Risk Meets Holiday Travel Tailwinds

Booking Holdings (BKNG) Stock News, Forecasts, and Analysis for Dec. 20, 2025: Court Ruling Risk Meets Holiday Travel Tailwinds

A Berlin court ruled Booking.com and its German subsidiary are liable to compensate 1,099 hotels for damages tied to past “best price” clauses, with damages to be determined later. BKNG last traded near $5,394, up 0.95% for the week, after swings following the ruling. The stock remains about 8.5% below its 52-week high.
21 December 2025
·
ON Semiconductor (ON) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 20, 2025

ON Semiconductor (ON) Stock: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 20, 2025

ON Semiconductor shares traded at $55.21 on Dec. 20, 2025, ahead of their removal from the Nasdaq-100 index effective Dec. 22. The company announced a $6 billion share buyback starting Jan. 1, 2026, and secured €450 million in Czech state aid for a European silicon carbide facility. On Dec. 18, onsemi unveiled a GaN partnership with GlobalFoundries targeting 650V power devices.
21 December 2025
·
Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

Vertex Pharmaceuticals reported new pediatric results for Casgevy on Dec. 6, showing all four children with severe sickle cell disease were free of vaso-occlusive crises for at least 12 months. Twelve pediatric beta thalassemia patients remained transfusion-free for at least a year. Vertex plans global regulatory filings in 2026. One TDT patient died from busulfan-related complications.
21 December 2025
··
Analog Devices (ADI) Stock News & Forecast: Wall Street Lifts Targets Up to $350 as AI Infrastructure and Industrial Recovery Drive 2026 Outlook (Dec. 20, 2025)

Analog Devices (ADI) Stock News & Forecast: Wall Street Lifts Targets Up to $350 as AI Infrastructure and Industrial Recovery Drive 2026 Outlook (Dec. 20, 2025)

Analog Devices shares closed at $274.44 on December 20, 2025, near recent highs after a strong fiscal Q4 and positive Q1 outlook. Cantor Fitzgerald, Bank of America, UBS, Truist, and Morgan Stanley all raised price targets, citing AI infrastructure demand. Insider selling by a senior executive and director was disclosed. Analyst consensus price targets now range from $282 to $350, with most ratings at Buy or Hold.
20 December 2025
SanDisk (SNDK) Stock: Today’s News, Analyst Targets, and Fresh 2026–2027 Forecasts (Dec. 20, 2025)

SanDisk (SNDK) Stock: Today’s News, Analyst Targets, and Fresh 2026–2027 Forecasts (Dec. 20, 2025)

SanDisk shares closed at $237.61 on Friday, up $18.09 or 8.24% after a sector-wide rally sparked by Micron’s strong AI-driven outlook. The stock saw volatile trading between $220 and $243.67. Analyst targets have risen, with Benchmark at $260 and Citi at $280, citing expectations of tight memory supply and strong demand through 2027. U.S. markets remain closed Saturday.
20 December 2025
·
Coca-Cola Stock (NYSE: KO) News, Forecasts, and Analyst Outlook on Dec. 20, 2025

Coca-Cola Stock (NYSE: KO) News, Forecasts, and Analyst Outlook on Dec. 20, 2025

Coca-Cola shares closed near $70 on Friday, close to their 52-week high of $74.38, with a market cap above $300 billion. The company announced Henrique Braun will become CEO on March 31, 2026, as James Quincey moves to executive chairman. KO trades at a premium valuation, with a P/E in the low-to-mid 20s. Investors are watching the CEO transition and ongoing portfolio strategy.
20 December 2025
·
Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase launched stock trading and prediction markets in its main app this week, expanding beyond crypto. Shares last traded near $245.12, up 2.47% on volume of about 10.6 million. The company faces new legal disputes over state restrictions on prediction markets. Analysts say Coinbase is pushing to become a multi-asset “everything exchange.”
20 December 2025
··
KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation shares closed at $1,245.67 on Dec. 19, up 1.90% and near technical buy points after Jefferies upgraded the stock to “Buy” and raised its price target to $1,500. The move follows volatile trading and new industry forecasts projecting further growth in chipmaking equipment demand tied to AI infrastructure spending.
20 December 2025
··
Carnival Corporation Stock (CCL) News: Dividend Returns, 2026 Outlook, Analyst Price Targets and Key Risks (Updated Dec. 20, 2025)

Carnival Corporation Stock (CCL) News: Dividend Returns, 2026 Outlook, Analyst Price Targets and Key Risks (Updated Dec. 20, 2025)

Carnival shares jumped nearly 10% Friday, closing at $31.12 after the company reinstated its quarterly dividend and issued strong profit guidance for 2026. The cruise operator reported record annual revenue of $26.6 billion and adjusted net income of $3.1 billion for 2025. Fourth-quarter net income reached $422 million. Carnival also announced a plan to streamline its dual-listed structure.
20 December 2025
··
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

BioMarin Pharmaceutical will acquire Amicus Therapeutics for $14.50 per share in cash, valuing the deal at about $4.8 billion. Amicus shares closed at $14.18 on December 19, reflecting a small merger spread tied to regulatory and deal-closing risks. Both boards approved the agreement. Closing is targeted for Q2 2026, pending shareholder and antitrust approvals.
20 December 2025
···
Uber Stock (NYSE: UBER) News on Dec. 20, 2025: Uber One Lawsuit, Robotaxi Momentum, and Analyst Forecasts Heading Into 2026

Uber Stock (NYSE: UBER) News on Dec. 20, 2025: Uber One Lawsuit, Robotaxi Momentum, and Analyst Forecasts Heading Into 2026

Uber stock closed at $79.31 on Dec. 20, down about 20% from its fall peak but still up for the year. The U.S. FTC, 21 states, and D.C. filed an amended lawsuit against Uber over its Uber One subscription practices, alleging unauthorized charges and difficult cancellation. Uber denies the claims. The case is in federal court in California.
20 December 2025
··
Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining shares closed at $19.67 on Dec. 20, 2025, after hitting a 52-week high of $20.20 amid record silver prices above $65/oz. The stock is set to join the S&P MidCap 400 on Dec. 22, a move expected to boost trading volume. Hecla reported a key permit approval for its 2026 Polaris exploration program in Nevada. Year-to-date, HL has gained nearly 290%.
20 December 2025
··
Newmont Corporation Stock (NEM) News Today: Latest Updates, Gold Price Forecasts, Analyst Targets, and 2026 Outlook (20 December 2025)

Newmont Corporation Stock (NEM) News Today: Latest Updates, Gold Price Forecasts, Analyst Targets, and 2026 Outlook (20 December 2025)

Newmont shares closed at $101.29 on Friday, December 19, 2025, up 1.96% and just below their 52-week high. Trading volume surged to 27.6 million shares, well above the 50-day average. The move comes as gold prices remain strong, with major banks forecasting gold at $4,800–$4,900/oz for 2026. Investors remain active, keeping Newmont near the top of mining sector watchlists.
20 December 2025
··
American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

American Express shares traded near $376.51, close to 52-week highs, as investors weighed strong holiday spending growth against possible changes to premium card pricing in late 2025. U.S. retail consumer spending on Amex cards rose 9% around Thanksgiving, with Platinum card spending up 13%. The Federal Reserve’s December rate cut added uncertainty to the outlook.
20 December 2025
·
Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Philip Morris International closed at $156.84 on Friday, with after-hours trading lifting shares to $157.98. Investors are watching an upcoming FDA advisory panel on January 22, 2026, regarding modified-risk claims for ZYN nicotine pouches. Oak Thistle LLC cut its PM stake in Q3, though institutional ownership remains high at 78.63%. PM’s next earnings are scheduled for February 5, 2026.
20 December 2025
·
Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences shares closed at $124.29 on Dec. 19, up 2.32%, after President Trump announced a drug pricing deal with nine major firms, including Gilead. The agreement includes Medicaid price cuts, cash-pay discounts via TrumpRx.gov, and a three-year tariff exemption tied to increased U.S. manufacturing. Gilead expects the financial impact to be manageable in 2026.
20 December 2025
··
Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Intuit closed Friday, Dec. 19 at $671.30 after rebounding from early-week losses. The stock remains well below its July 52-week high of $813.70. Intuit announced a multi-year partnership with Circle to integrate USDC stablecoin features into TurboTax, QuickBooks, and Credit Karma. No revenue targets were disclosed.
20 December 2025
··
Caterpillar (CAT) Stock Today: Latest News, Analyst Forecasts, and 2026 Outlook as AI Power Demand Meets Tariffs and Legal Risk

Caterpillar (CAT) Stock Today: Latest News, Analyst Forecasts, and 2026 Outlook as AI Power Demand Meets Tariffs and Legal Risk

Caterpillar shares traded near $576 on Dec. 20, 2025, after a 4.6% single-day drop earlier in the week, its worst five-day stretch since April. The stock has surged in 2025 on record backlog and rising demand for power equipment from data centers, but faces pressure from tariffs, valuation concerns, and legal issues. The company maintained its $1.51 quarterly dividend and reported Q3 sales up 10% to $17.6 billion.
20 December 2025
·
1 … 1,280 1,281 1,282 1,283 1,284 … 2,088

Stock Market Today

  • Birchcliff Energy (TSX:BIR) Shares Appear 38% Undervalued Despite High P/E
    June 21, 2026, 1:31 AM EDT. Birchcliff Energy (TSX:BIR) announced a quarterly dividend of CA$0.03, alongside a 6% increase in production year-over-year. At CA$6.44 per share, Birchcliff's stock has dropped 6.12% in the past month and 15.60% over the last quarter. The stock trades at a price-to-earnings (P/E) ratio of 25.6, above the Canadian oil and gas sector average of 24.4, suggesting a premium valuation. However, discounted cash flow (DCF) analysis estimates a fair value of CA$10.42, implying the stock may be undervalued by approximately 38%. Investors should consider risks related to Canadian oil and gas market exposure and commodity price sensitivity before reassessing holdings.

Latest articles

Home Depot shares finish week up as investors weigh housing numbers

Home Depot shares finish week up as investors weigh housing numbers

21 June 2026
Home Depot jumped 2.1% to $334.28 in a shortened week as Wall Street rallied, but weak U.S. housing starts and upcoming May new-home-sales data keep pressure on the home-improvement outlook; the company reaffirmed 2026 sales and earnings targets despite volatile conditions and persistent housing affordability concerns.
Go toTop